市场对包括 Ozempic 和 Wegovy 等流行品牌在内的减肥药物的需求持续上升。 最近的一项研究显示，八分之一的美国人曾经或正在使用这些药物来控制糖尿病、心脏病或肥胖症。这些药物被正式归类为胰高血糖素样肽-1 受体激动剂（GLP-1RA），包括 ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

为糖尿病预防提供了新策略 ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

科学家们可能已经发现了一种自然调节血糖水平和对糖的渴望的方法，其方式与Ozempic等药物类似。 在小鼠和人类身上，解开这一自然过程的关键被发现是肠道微生物及其代谢物 —— 它在消化过程中产生的化合物。

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...